Literature DB >> 26066409

Insulin resistance as a predictor of cardiovascular morbidity and end-stage renal disease.

André Fragoso1, Filipa Mendes2, Ana Paula Silva3, Pedro Leão Neves3.   

Abstract

BACKGROUND: Cardiovascular disease (CVD) is the main risk factor of morbidity and mortality in chronic kidney disease (CKD) patients. Insulin resistance (IR) has been reported to be a strong risk factor for CVD. The purpose of this study was to examine the usefulness of IR as a predictor of cardiovascular morbidity and end-stage renal disease (ESRD).
METHODS: We followed during a period of 56months 119 type 2 diabetic CKD patients (stages 2 to 4) without history of CVD at the beginning of the study. Several laboratory parameters and left ventricular mass index (LVMI) were analyzed. The degree of IR was estimated by the Homeostasis Model Assessment (HOMA-IR). Cardiovascular morbidity was assessed according to the presence of cardiovascular hospital admission during the study period, defined by admissions caused by coronary heart disease, congestive heart failure, peripheral vascular disease and cerebrovascular disease. The population was divided in two groups: G-1 with cardiovascular admission (n=48) and G-2: without admission (n=71). The multiple logistic regression was used to assess predictors of cardiovascular morbidity and ESRD. The renal survival was evaluated by the Kaplan-Meier and long-rank test.
RESULTS: We found that G-1 patients showed significantly higher HOMA-IR (3.8 vs 0.77, p=0.0001) and that HOMA-IR upper tercile showed significantly higher age, eGFR, LVMI, phosphorus, iPTH and IL-6. In a multivariate logistic regression model HOMA-IR and IL-6 were independent risk factors of cardiovascular morbidity (OR=2.847 [95% CI 1.048-7.735, p=0.012] and OR=2.483 [95% CI 1.221-5.049, p=0.04], respectively). In a univariate logistic regression model patients in the upper tercile presented significantly more cardiovascular admissions that in the lower tercile. CKD progression to ESRD was observed in 24 patients and those in the upper HOMA-IR tercile showed a higher CKD progression to ESRD than the rest of study patients. A multivariate logistic regression model showed that HOMA-IR (OR=1.034, 95% CI (1.005-1.650) p=0.040) was an independent predictor of ESRD. Kaplan-Meier analysis showed a difference in renal survival in the HOMA-IR terciles (log rank=8.093; p=0.017).
CONCLUSION: In our study IR is an important risk factor for cardiovascular morbidity and ESRD in a diabetic CKD population.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CKD; CKD progression; Cardiovascular disease; Diabetic nephropathy; ESRD; Insulin resistance

Mesh:

Substances:

Year:  2015        PMID: 26066409     DOI: 10.1016/j.jdiacomp.2015.05.010

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  9 in total

1.  Triglyceride-Glucose Index and Homeostasis Model Assessment-Insulin Resistance in Young Adulthood and Risk of Incident Congestive Heart Failure in Midlife: The Coronary Artery Risk Development in Young Adults Study.

Authors:  Xianghui Zeng; Dunzheng Han; Haobin Zhou; Yuting Xue; Xiao Wang; Qiong Zhan; Yujia Bai; Xingfu Huang; Qingchun Zeng; Hao Zhang; Zhuang Ma; Hao Ren; Dingli Xu
Journal:  Front Cardiovasc Med       Date:  2022-06-30

2.  Excessive Autophagy Activation and Increased Apoptosis Are Associated with Palmitic Acid-Induced Cardiomyocyte Insulin Resistance.

Authors:  Shanxin Li; Hui Li; Di Yang; Xiuyan Yu; David M Irwin; Gang Niu; Huanran Tan
Journal:  J Diabetes Res       Date:  2017-11-26       Impact factor: 4.011

3.  Higher glomerular filtration rate is related to insulin resistance but not to obesity in a predominantly obese non-diabetic cohort.

Authors:  Negar Naderpoor; Jasmine G Lyons; Aya Mousa; Sanjeeva Ranasinha; Maximilian P J de Courten; Georgia Soldatos; Barbora de Courten
Journal:  Sci Rep       Date:  2017-04-03       Impact factor: 4.379

4.  Insulin Resistance and Cardiovascular Risks in Different Groups of Hemodialysis Patients: A Multicenter Study.

Authors:  Tuyen Van Duong; Chun-Kuang Shih; Te-Chih Wong; Hsi-Hsien Chen; Tso-Hsiao Chen; Yung-Ho Hsu; Sheng-Jeng Peng; Ko-Lin Kuo; Hsiang-Chung Liu; En-Tzu Lin; Chien-Tien Su; Shwu-Huey Yang
Journal:  Biomed Res Int       Date:  2019-06-11       Impact factor: 3.411

5.  Impact of Percent Body Fat on All-Cause Mortality among Adequate Dialysis Patients with and without Insulin Resistance: A Multi-Center Prospective Cohort Study.

Authors:  Tuyen Van Duong; Te-Chih Wong; Hsi-Hsien Chen; Tso-Hsiao Chen; Yung-Ho Hsu; Sheng-Jeng Peng; Ko-Lin Kuo; Hsiang-Chung Liu; En-Tzu Lin; Shwu-Huey Yang
Journal:  Nutrients       Date:  2019-06-09       Impact factor: 5.717

6.  Comparison of Novel Metabolic Indices in Estimation of Chronic Kidney Diseases in a Southern Chinese Population.

Authors:  Tong Chen; Xuan Wang; Xin Wang; Haishan Chen; Hua Xiao; Hongjuan Tang; Ling Feng; Zhicong Xiang; Hequn Zou; Xiaofei Shao
Journal:  Diabetes Metab Syndr Obes       Date:  2020-12-10       Impact factor: 3.168

Review 7.  Insulin Resistance and Type 2 Diabetes Mellitus: An Ultimatum to Renal Physiology.

Authors:  Susmita Sinha; Mainul Haque
Journal:  Cureus       Date:  2022-09-08

8.  The triglyceride-glucose index as a novel marker associated with sarcopenia in non-diabetic patients on maintenance hemodialysis.

Authors:  Ruoxin Chen; Liuping Zhang; Mengyan Zhang; Ying Wang; Dan Liu; Zuolin Li; Xiaoliang Zhang; Hui Jin; Bicheng Liu; Hong Liu
Journal:  Ren Fail       Date:  2022-12       Impact factor: 3.222

9.  Association between resistin and fibroblast growth factor 23 in patients with type 2 diabetes mellitus.

Authors:  Akio Nakashima; Keitaro Yokoyama; Daiji Kawanami; Ichiro Ohkido; Mitsuyoshi Urashima; Kazunori Utsunomiya; Takashi Yokoo
Journal:  Sci Rep       Date:  2018-09-18       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.